Medical Countermeasures U.S. Commits $50 Million to Develop Countermeasures for Bundibugyo Ebola Strain Amid Growing DRC OutbreakGlobal Biodefense StaffJune 12, 2026
Medical Countermeasures CEPI Funds Three Bundibugyo Ebolavirus Vaccine Candidates, Including Oxford’s ChAdOx1-Based ApproachGlobal Biodefense StaffJune 1, 2026
Medical Countermeasures The Mpox Vaccine Works — But Its Immunity Fades Fast. A Third Dose May Help.Global Biodefense StaffMay 19, 2026
Notable Biodefense Contracts: AnaptysBio to Develop Anti-Ricin Antibodies Industry News May 20, 2013 …
Development of In Vitro Technologies for Evaluation of CBRN Countermeasures Contracts + Grants May 20, 2013 …
NHRC, Mayo Clinic Study Immune Response Following Smallpox Vaccination Defense + Military May 17, 2013 …
FDA Seeks Handheld Spectrometers for Field Analysis of Medical Countermeasures Biodetection May 7, 2013 …
Scientists Pursue New Therapies as Deadly H7N9 Flu Spreads in China Medical Countermeasures May 3, 2013 …
Glaxo Teams with Texas A&M for Influenza Manufacturing Center of Excellence Industry News April 5, 2013 …
Study of Virus-Killing Bacteria Motion Advances Nanotechnology Medical Countermeasures April 1, 2013 …
